ESC Premium Access

Implant procedure and lead handling characteristics of a novel active fixation quadripolar lead: Results from the Attain Stability Quad clinical trial

Congress Presentation

About the speaker

Professor Svein Faerestrand

University of Bergen, Bergen (Norway)
0 follower

8 more presentations in this session

His bundle pacing in patients pacemaker indication and with mildly reduced ejection fraction

Speaker: Mr R. Gardas (Katowice, PL)


Differential effect of CRT in ischemic and non-ischemic cardiomyopathy: longterm follow-up data from a single center cohort study

Speaker: Doctor P. Kahr (Schlieren, CH)


Cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy and severe heart failure may influence the development of unstable ventricular tachycardia

Speaker: Doctor D. Lebedev (Kemerovo, RU)


Atrioventricular optimization in cardiac resynchronization therapy with quadripolarleads, improves energy handling and quality of life in heart failure patients: HUMVEE Trial

Speaker: Doctor C. Antoniou (Athens, GR)


Are there shock incidence and mortality differences in primary prevention patients regarding device type and ischemia? A NORDIC ICD sub-study.

Speaker: Professor H. Bonnemeier (Luebeck, DE)


Access the full session

Poster Session 5 - Heart failure devices: new approaches

Speakers: Professor S. Faerestrand, Mr R. Gardas, Doctor P. Kahr, Doctor D. Lebedev, Doctor C. Antoniou...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb